Coffee and Longevity: What Do Large Cohort Studies Show?

Coffee is one of the most widely consumed beverages in the world, and at the same time one of the most commonly demonized — blamed in popular belief for raising blood pressure, straining the heart, or dehydrating the body. For decades, epidemiological research on coffee was also hampered by a so-called confounding factor: heavy coffee drinkers were also more likely to smoke, which blurred the picture of coffee's actual effect on health, separate from the effect of smoking.

Newer, large cohort studies, with much bigger samples and better statistical methods for controlling confounders, have finally managed to separate these two effects. The result that emerges is surprisingly consistent — and, contrary to popular intuition, mostly points to a protective, not harmful, link between coffee and lifespan.

One of the most compelling sources on this topic is the 2017 study by Park and colleagues, published in Annals of Internal Medicine, based on data from the Multiethnic Cohort Study — a project designed specifically to account for ethnic diversity, which many earlier coffee studies overlooked, despite the fact that caffeine metabolism and consumption patterns differ across populations.

A single cohort study, even one as large as the Multiethnic Cohort Study, covers one population and one set of statistical methods. To assess whether a similar pattern repeats consistently across the whole available literature, it's worth turning to a so-called umbrella review — an analysis that doesn't pool individual studies, but systematically summarizes the results of many already-existing meta-analyses on a given topic.

It's worth noting the shape of this relationship: in both sources discussed, the benefit didn't keep growing indefinitely with higher consumption. In Park and colleagues' study, the reduced death risk was similar at 2-3 cups and at 4 or more cups a day (HR 0.82 in both groups) — not gradually decreasing with higher intake. Poole and colleagues' review pointed to the lowest risk at three to four cups a day, suggesting a plateau rather than a linear increase in benefit.

Individual sensitivity to caffeine also varies significantly between people, largely due to genetic variants of the CYP1A2 enzyme, responsible for caffeine metabolism in the liver — which we describe in more depth in our caffeine entry. People who metabolize caffeine slowly may experience its negative effects (including worse sleep quality) at doses that pass almost unnoticed in fast metabolizers.

In practice, this means regular, moderate coffee drinking isn't something a healthy adult without contraindications needs to avoid out of concern for lifespan — the data suggests quite the opposite. More important than cutting out coffee entirely is paying attention to timing (avoiding it in the second half of the day if it affects sleep) and individual tolerance.

Coffee belongs to a small group of widely consumed products where large, independent studies consistently point to a protective, not harmful, association with lifespan — contrary to some popular beliefs. What makes this conclusion credible is the repeatability of the effect across different populations and methodologies, not one loud, single study.

For a healthy adult without specific contraindications, moderate, regular coffee drinking (2-4 cups a day, accounting for time of day and individual tolerance) seems like a reasonable, well-documented lifestyle element, not something to avoid out of concern for health.